Jim Hill

Chief Operating Officer and Director at Defender Pharmaceuticals
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Chief Operating Officer and Director
      • Dec 2018 - Present

    • Pharmaceutical Manufacturing
    • Chief Executive Officer
      • 2008 - Present

      Pharma Strategy Group provides a wide range of strategic consulting services to the pharmaceutical industry and Wall St investment community to assist them in identifying and leveraging market opportunities. Our expertise, combined with a network of industry experts and key decision makers in managed markets, allows us to bring strategies and tactics together to create innovative solutions for our clients. Pharma Strategy Group provides a wide range of strategic consulting services to the pharmaceutical industry and Wall St investment community to assist them in identifying and leveraging market opportunities. Our expertise, combined with a network of industry experts and key decision makers in managed markets, allows us to bring strategies and tactics together to create innovative solutions for our clients.

    • Pharmaceutical Manufacturing
    • Chief Executive Officer
      • Apr 2013 - Present

      AcquireRx provides a number of pharmaceutical rebate management services including rebate aggregation and acquisition services for payors and rebate contract processing for pharmaceutical companies. AcquireRx provides a number of pharmaceutical rebate management services including rebate aggregation and acquisition services for payors and rebate contract processing for pharmaceutical companies.

    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Co-Founding Partner and Former Board Member
      • Apr 2016 - Dec 2021

      Optime Care was acquired by AscellaHealth in December 2021. AscellaHealth is an innovative Pharmacy Benefit Manager that focuses on providing custom and tailored pharmacy benefit management services to its clients. Focus on the client and their needs are the most important initiatives. Ascella provides dynamic management services for specialty pharmaceuticals and robust clinical programs to stay ahead of the evolving pharmacy practice. Optime Care was acquired by AscellaHealth in December 2021. AscellaHealth is an innovative Pharmacy Benefit Manager that focuses on providing custom and tailored pharmacy benefit management services to its clients. Focus on the client and their needs are the most important initiatives. Ascella provides dynamic management services for specialty pharmaceuticals and robust clinical programs to stay ahead of the evolving pharmacy practice.

  • Providence Biotechnology Solutions
    • Warwick, United Kingdom
    • Former Chairman of the Board
      • 2007 - Jul 2015

      Providence Biotechnology Solutions Ltd. (PBS) is a privately held biotechnology company which specializes in the design, patent, and marketing of transdermal medical device technology for the treatment of a range of medical conditions. Providence Biotechnology Solutions Ltd. (PBS) is a privately held biotechnology company which specializes in the design, patent, and marketing of transdermal medical device technology for the treatment of a range of medical conditions.

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • VP, Pharmaceutical Trade Relations
      • Dec 1996 - Mar 2008

    • Assistant Administrator
      • 1991 - 1996

Education

  • Saint Louis University
    MBA, Finance
    1993 - 1996
  • Stanford University Graduate School of Business
    Executive MBA Program- Influence and Negotiation Strategy
    2008 - 2008
  • St. Louis College of Pharmacy
    BS, Pharmacy
    1979 - 1984

Community

You need to have a working account to view this content. Click here to join now